The FDA has proposed reclassifying medical image analyzers used in mammography for breast cancer, ultrasound for breast lesions, x-ray for lung nodules and x-ray for dental caries as class II medical devices instead of class III.

This shouldn't be too surprising, but you can't always believe what you read on the internet. The online consumer ratings of healthcare providers are highly skewed, differ by specialty and fall within narrow margins, according to a study published May 9 in the Journal of Medical Internet Research.

False-positive breast biopsies cost the U.S. healthcare system approximately $2.18 billion each year, according to a study published in ClinicoEconomics and Outcomes Research.

Researchers from Hannover Medical School in Germany have developed a tablet-based symptom drawing application to provide clinicians and patients with a way to assess pain. The team published its findings May 30 in JMIR mHealth and uHealth.

President Donald Trump announced on Tuesday, May 29, that proposed tariffs on $50 billion worth of Chinese imported goods, including medical imaging equipment, are back on the table.

On Tuesday, May 29, President Donald Trump indicated the U.S. would proceed with its planned tariffs on $50 billion in Chinese imports.

An initiative to boost Scotland’s radiologist count by at least 10 percent in the midst of a national shortage “has failed,” The Herald Scotland reported, leaving cancer patients across the country without access to potentially life-saving treatments.

Patients who are nonwhite and less educated value patient portals to view clinician notes more than white and educated patients, according to a study published May 24 in the Journal of Medical Internet Research.